Audited Results of Aurobindo Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	10,933.30	10,645.64	12,792.28	11,287.14	15,823.68
Manufacturing Expenses	185.59	191.58	613.92	477.99	512.34
Personnel Expenses	1,063.07	980.56	1,641.88	1,600.04	1,735.42
Selling Expenses	0	0	0	0	0
Administrative Expenses	1,446.43	1,332.04	1,795.57	1,754.34	2,030.53
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	8,375.73	8,421.60	11,061.36	9,813.74	11,703.85
Operating Profit	2,557.57	2,224.04	1,730.92	1,473.40	4,119.83
Other Recurring Income	328.12	616.06	433.76	670.99	589.86
Adjusted PBDIT	2,885.69	2,840.10	2,164.68	2,144.39	4,709.69
Financial Expenses	230.04	182.60	114.98	16.94	28.68
Depreciation	297.20	254.58	435.35	415.26	488
Other Write offs	0	0	0	0	0
Adjusted PBT	2,358.45	2,402.92	1,614.35	1,712.19	4,193.01
Tax Charges	611.66	502.82	383.94	182.77	1,080.10
Adjusted PAT	1,746.79	1,900.10	1,230.41	1,529.42	3,112.91
Non Recurring Items	-5.26	52.35	5.87	-73.02	-6.42
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	1,746.79	1,954.14	1,230.41	1,454.71	3,112.91
Equity Dividend	0	263.66	439.45	263.67	234.38
Preference Dividend	0	0	0	0	0
Retained Earnings	20,090.40	18,348.87	16,660.97	15,864.14	14,671.41

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article